StockNews.com upgraded shares of GlycoMimetics (NASDAQ:GLYC – Free Report) from a sell rating to a hold rating in a research note published on Tuesday. Separately, Capital One Financial began coverage on GlycoMimetics in a report on Friday, December 22nd. They issued an overweight rating and a $12.00 price objective for the company. Get Our Latest […]
Related Keywords
United States , , Millennium Management , Renaissance Technologies , Marshall Wace , Glycomimetics Inc , Free Report , Capital One Financial , Get Free Report , Sigma Investments , State Street Corp , Street Corp , Glycomimetics Daily , Glycomimetics , Nasdaq Glyc , Glyc , Medical , Upgrade , Stocknews Com ,
comparemela.com © 2020. All Rights Reserved.